CD8A and neoplasm: It is well recognized that cytotoxic T lymphocytes (CD8+ T cells) are crucial components of antitumour immunity, since activated CD8+ T cells can directly kill tumour cells by the release of granules including lytic components such as perforin and enzymatic proteases (like granzyme B, GZMB) [10]–[12].